CD4+CD25+ regulatory T cells decreased future liver remnant after associating liver partition and portal vein ligation for staged hepatectomy

Table 1 Baseline index data of hepatocellular carcinoma patients undergoing association liver partition and portal vein ligation for staged hepatectomy

Variable	ALPPS, n = 37
Age, yr	45 (26-75)
Sex, women/man, n (%)	3 (8.1)/34 (91.9)
BMI, kg/m2	22.2 (17.99-30.09)
AFP, ≥ 400 ng/mL/< 400 ng/mL, n (%)	19 (51.4)/18 (48.6)
Degree of liver fibrosis, n
No fibrosis	7
Mild fibrosis	2
Moderate fibrosis/fibrosis	8
Cirrhosis, n (%)	20 (54.1)
MELD score	5.12 (0.75-11.00)
ICGR15, %	5.3 (1.3-18.8)
Child-Pugh class, A/B/C, n	36/1/0
BCLC staging, A/B/C, n	10/7/20

AFP: Alpha-fetoprotein; ALPPS: Association liver partition and portal vein ligation for staged hepatectomy; BCLC: Barcelona Clinic Liver Cancer; BMI: Body mass index; ICGR15: Indocyanine green retention rate at 15 min; MELD: Model for end-stage liver disease.